{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:33:31Z","timestamp":1786116811817,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.05.011","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:13:02Z","timestamp":1786018382000},"page":"535-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Psychotropic Medications During Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Edwin R.","family":"Raffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Nonacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clp.2026.05.011_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1087054720975864","article-title":"The course of ADHD during pregnancy","volume":"26","author":"Baker","year":"2022","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clp.2026.05.011_bib2","first-page":"374","article-title":"Pregnancy-related substance use in the United States during 1996\u20131998","volume":"101","author":"Ebrahim","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.011_bib3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/phar.1958","article-title":"Methadone, buprenorphine, and naltrexone for the treatment of opioid use disorder in pregnant women","volume":"37","author":"Tran","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clp.2026.05.011_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.pra.0000351878.45260.94","article-title":"Use and safety of antipsychotic drugs during pregnancy","volume":"15","author":"Einarson","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.clp.2026.05.011_bib5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.clp.2026.05.011_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jamapsychiatry.2022.4109","article-title":"Association of in utero antipsychotic medication exposure with risk of congenital malformations in Nordic countries and the US","volume":"80","author":"Huybrechts","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.clp.2026.05.011_bib8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","article-title":"Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age","volume":"181","author":"Wang","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clp.2026.05.011_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study","volume":"66","author":"McKenna","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","article-title":"Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study","volume":"33","author":"Habermann","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clp.2026.05.011_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/appi.ajp.2015.15040506","article-title":"Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital national pregnancy registry for atypical antipsychotics","volume":"173","author":"Cohen","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.schres.2016.07.023","article-title":"Risks associated with antipsychotic treatment in pregnancy: comparative cohort studies based on electronic health records","volume":"176","author":"Petersen","year":"2016","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clp.2026.05.011_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcpt.12372","article-title":"Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations: a systematic review","volume":"116","author":"Ennis","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.clp.2026.05.011_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamainternmed.2022.0375","article-title":"Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study","volume":"182","author":"Straub","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.clp.2026.05.011_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-022-00908-2","article-title":"Antipsychotic use during pregnancy and risk for gestational diabetes: a national register-based cohort study in Sweden","volume":"36","author":"Heinonen","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clp.2026.05.011_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.clp.2026.05.011_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(75)90548-6","article-title":"Association between cleft lip with or without cleft palate and prenatal exposure to diazepam","volume":"2","author":"Safra","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2026.05.011_bib18","article-title":"First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study","volume":"9","author":"Ban","year":"2014","journal-title":"Public Libr Sci One"},{"key":"10.1016\/j.clp.2026.05.011_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.genhosppsych.2012.09.003","article-title":"Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview","volume":"35","author":"Bellantuono","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","article-title":"The fetal safety of benzodiazepines: an updated meta-analysis","volume":"33","author":"Enato","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"issue":"12","key":"10.1016\/j.clp.2026.05.011_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/da.23280","article-title":"Risk of major malformations in infants after first-trimester exposure to benzodiazepines: results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications","volume":"39","author":"Szpunar","year":"2022","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.clp.2026.05.011_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.genhosppsych.2018.05.010","article-title":"Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: results from a prospective registry of women with psychiatric disorders","volume":"53","author":"Freeman","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapsychiatry.2017.2733","article-title":"Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes","volume":"74","author":"Yonkers","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib24","first-page":"34S","article-title":"Neonatal apnea associated with maternal clonazepam therapy: a case report","volume":"66","author":"Fisher","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.011_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.282.6270.1106","article-title":"Effect of maternal lorazepam on the neonate","volume":"282","author":"Whitelaw","year":"1981","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.clp.2026.05.011_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2215-0366(23)00148-7","article-title":"Association between maternal benzodiazepine or Z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan","volume":"10","author":"Meng","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.clp.2026.05.011_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000529141","article-title":"Maternal benzodiazepines and Z-drugs use during pregnancy and adverse birth and neurodevelopmental outcomes in offspring: a population-based cohort study","volume":"92","author":"Chan","year":"2023","journal-title":"Psychother Psychosom"},{"issue":"3","key":"10.1016\/j.clp.2026.05.011_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003945","article-title":"First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: a population-based cohort study in South Korea","volume":"19","author":"Noh","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.clp.2026.05.011_bib29","first-page":"289","article-title":"Postpartum course in women with preexisting panic disorder","volume":"55","author":"Cohen","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib30","first-page":"156","article-title":"Postpartum obsessive compulsive disorder: a case series","volume":"54","author":"Sichel","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000056242","article-title":"Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series","volume":"70","author":"Weinstock","year":"2001","journal-title":"Psychother Psychosom"},{"issue":"5","key":"10.1016\/j.clp.2026.05.011_bib32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00737-022-01250-8","article-title":"Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National pregnancy Registry for Psychiatric Medications","volume":"25","author":"Freeman","year":"2022","journal-title":"Arch Women\u2019s Ment Health"},{"key":"10.1016\/j.clp.2026.05.011_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1081-1206(10)63385-6","article-title":"Prospective controlled study of hydroxyzine and cetirizine in pregnancy","volume":"78","author":"Einarson","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clp.2026.05.011_bib34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0747","article-title":"Perinatal outcomes after treatment with ADHD medication during pregnancy","volume":"140","author":"N\u00f6rby","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.clp.2026.05.011_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/jamapsychiatry.2023.5073","article-title":"Prescription stimulant use during pregnancy and risk of neurodevelopmental disorders in children","volume":"81","author":"Suarez","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.clp.2026.05.011_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ije\/dyac180","article-title":"The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions","volume":"52","author":"Camacho","year":"2023","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.011_bib37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/JCP.0000000000001702","article-title":"Risk of major malformations in infants after first-trimester exposure to stimulants: results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications","volume":"43","author":"Szpunar","year":"2023","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.clp.2026.05.011_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43648","article-title":"Methylphenidate and atomoxetine in pregnancy and possible adverse fetal outcomes: a systematic review and meta-analysis","volume":"7","author":"di Giacomo","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clp.2026.05.011_bib39","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4088\/JCP.15m10506","article-title":"Prenatal psychostimulant and antidepressant exposure and risk of hypertensive disorders of pregnancy","volume":"77","author":"Newport","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.011_bib40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/GRF.0000000000000098","article-title":"Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations","volume":"58","author":"Krans","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.011_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cct.2014.08.009","article-title":"Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome","volume":"39","author":"Winhusen","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.clp.2026.05.011_bib42","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.011_bib43","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.011_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"issue":"22","key":"10.1016\/j.clp.2026.05.011_bib45","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clp.2026.05.011_bib46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamainternmed.2023.6986","article-title":"First trimester use of buprenorphine or methadone and the risk of congenital malformations","volume":"184","author":"Suarez","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.clp.2026.05.011_bib47","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/10826084.2022.2083174","article-title":"Buprenorphine compared with methadone in pregnancy: a systematic review and meta-analysis","volume":"57","author":"Kinsella","year":"2022","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.clp.2026.05.011_bib48","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","volume":"11","author":"Minozzi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.clp.2026.05.011_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40264-022-01267-z","article-title":"Comparative safety analysis of opioid agonist treatment in pregnant women with opioid use disorder: a population-based study","volume":"46","author":"Wang","year":"2023","journal-title":"Drug Saf"},{"key":"10.1016\/j.clp.2026.05.011_bib50","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.clp.2026.05.011_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014","volume":"9","author":"Hirschtritt","year":"2018","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.clp.2026.05.011_bib52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.drugalcdep.2013.04.006","article-title":"Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes","volume":"132","author":"Schuman-Olivier","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.clp.2026.05.011_bib54","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","volume":"221","author":"Ecker","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2026.05.011_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ADM.0000000000000635","article-title":"Executive summary of the focused update of the ASAM national practice guideline for the treatment of opioid use disorder","volume":"14","author":"Crotty","year":"2020","journal-title":"J Addiction Med"},{"key":"10.1016\/j.clp.2026.05.011_bib56","series-title":"Treatment of opioid use disorder in the general hospital","author":"Funk","year":"2022"},{"key":"10.1016\/j.clp.2026.05.011_bib57","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1345\/aph.1P279","article-title":"Nicotine replacement therapy effect on pregnancy outcomes","volume":"44","author":"Forinash","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clp.2026.05.011_bib58","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1097\/AOG.0000000000002353","article-title":"ACOG committee opinion no. 721. Smoking cessation during pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.011_bib60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study","volume":"192","author":"Chun-Fai-Chan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.011_bib61","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pds.1296","article-title":"Bupropion in pregnancy and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.clp.2026.05.011_bib62","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ntr\/nty055","article-title":"Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy","volume":"21","author":"Turner","year":"2019","journal-title":"Nicotine Tob Res"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009551082600059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009551082600059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:15:13Z","timestamp":1786018513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009551082600059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S009551082600059X"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.011","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Psychotropic Medications During Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}